Dr. Nattanit Gregoris
Specialty
Medicine
Sub Specialty
Neurology
Language Spoken
Thai / EnglishProfessional Qualifications
- 3 April 2020: Certificate in Training (CCT) in Clinical neurophysiology, London, United Kingdom
- 10 March 2013: Membership of the Royal College of Physicians of The United Kingdom (MRCP(UK))
- 8 July 2010: Thai Board of Neurology
- 4 June 2010: Master of Science (MSc) in Medicine, Chulalongkorn University, Bangkok, Thailand
- 25 May 2007: Graduate Diploma of Clinical Science Degree in Internal Medicine, Chulalongkorn University, Bangkok, Thailand
- 19 Mar 2004: Doctor of Medicine (M.D.), Chulalongkorn University, Bangkok, Thailand
Education
- 2008-2010: Master of Science Programme in Medicine, Chulalongkorn University, Bangkok, Thailand
- 1998-2004: M.D. with Second Class Honors (GPAX = 3.34), Chulalongkorn University, Bangkok, Thailand
- 1992-1998: High School, Triam Udom Suksa School, Bangkok, Thailand
Postgraduate Training
- 10 October 2014: Introduction to Good Clinical Practice (GCP), National Institute for Health Research, UK
- 21 April 2013: Advanced Life Support Course (ALS), Royal National Orthopaedic Hospital, Resuscitation council (UK)
- July – August 2011: EEG/Epilepsy Intensive Course, 240 hours of EEG/Epilepsy Instruction, University Hospitals Case Medical Center, Cleveland, Ohio, USA
- 2010-2011: Fellowship in Epilepsy, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand
- 2007-2010: Residency Training in Neurology, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand
- 2006-2007: Residency Training in Internal Medicine, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand
Professional Experience
- 3 October 2022-5 April 2024: Consultant Neurophysiologist, St George’s Hospital, London, Croydon University Hospital, London
- 4 October 2021-30 Sep 2022: Consultant Neurophysiologist, Central Middlesex Hospital, LNWH NHS Trust, Charing Cross Hospital, Imperial College Healthcare NHS Trust
- 6 Apr 2020-1 Oct 2021: Locum consultant in Clinical Neurophysiology, St George’s Hospital, London, UK, Croydon University Hospital, London, UK
- 1 Oct 2019 – 1 Apr 2020: Clinical Neurophysiology registrar ST6, National Hospital for Neurology and Neurosurgery, London, UK
- 1 Apr 2019 – 30 Sep 2019: Clinical Neurophysiology Registrar ST5-ST6, Great Ormond Street Hospital, London, UK
- 2 Feb 2016 – 31 Mar 2019: Clinical Neurophysiology registrar ST3-ST5, National Hospital for Neurology and Neurosurgery, London, UK
- 5 Aug 2015 – 1 Feb 2016: Clinical Neurophysiology ST3, Great Ormond Street Hospital, London, UK
- Feb 2015 – Aug 2015: Trust Doctor ST3 Neurology (Stroke), St George’s Hospital, London, UK
- Aug 2014 – Feb 2015: Clinical Fellow in Neurology, The Royal London Hospital, London, United Kingdom
- Feb 2014 – Aug 2014: LAT ST3 Neurology, The Royal London Hospital, London, United Kingdom
- Aug 2013 – Feb 2014: SHO Neurology, Derriford Hospital, Plymouth, United Kingdom
- 2012-2013: Clinical Observer (Epilepsy), The National Hospital for Neurology and Neurosurgery, London, The United Kingdom
- 2005-2006: Attending Physician, Klongthom Hospital, Krabi, Thailand
- 2004-2005: Internship, Krabi Hospital, Krabi, Thailand
Professional Memberships
- 2014-Present: British Society for Clinical Neurophysiology
- 2014-2017: Association of British Neurologist
- 2013-2017: The Royal Colleges of Physicians (MRCP(UK), MRCP(London))
- 2012-Present: International League Against Epilepsy (ILAE)
- 2010-Present: The Neurological Society of Thailand
- 2010-Present: The Royal College of Physicians of Thailand
- 2004-Present: The Medical Council of Thailand
Medical Licensures
- General Medical Council, United Kingdom, Specialist Register, Clinical Neurophysiology (Date of Registration 3 April 2020)
- General Medical Council, United Kingdom, Full Registration, No. 7168820 (Date of Registration 14 May 2013)
- Medical Council of Thailand, No. 31060 (Date of Registration 01 January 2004)
Honours, Prizes And Awards
- 2004: Second Class Honour, Doctor of Medicine, M.D., Chulalongkorn University, Bangkok, Thailand
Grants
- 2009-2010: Ratchadapiseksompoch Research Fund (400,000 THB)
Publication – Peer-reviewed Journal Article
- 2019: Gregoris N, Bland J (2019) Is carpal tunnel syndrome in the elderly a separate entity? Evidence from median nerve ultrasound. Muscle Nerve. 2019 Sep;60(3): 217-218.
- 2013: Gregoris N, Shorvon S (2013) What is the enduring value of research publications in clinical epilepsy? An assessment of papers published in 1981, 1991, and 2001. Epilepsy Behav. 2013 Sep; 28(3):522-9.
Clinical Audit
- Dec 2014: Re-audit IVIg use in Neurology Planned Investigation Unit, Presented on 4th December 2014 at Neurosciences Quality and Safety Meeting, The Royal London Hospital, London, UK
- Nov 2017: Evaluation of electrodiagnosis of lumbosacral radiculopathies over six month period, Presented on 22nd November, 2017 at Neurophysiology Department Clinical Governance Meeting, National Hospital for Neurology and Neurosurgery, London, UK
- Nov 2018: Evaluation of neurophysiology studies for generalized neuropathy in one month’s period, Presented on 22nd November, 2018 at Neurophysiology Department Clinical Governance Meeting, National Hospital for Neurology and Neurosurgery, London, UK
Book Chapters
- Limpisook N, Lochareonkul C, Epilepsy Presurgical Evaluation. In Srikijvilaikul T, Textbook of Epilepsy Surgery, Bangkok, Chula Press (2009) (Thai)
- Limpisook N, Lochareonkul C, Surgically Remediable Syndromes. In Srikijvilaikul T, Textbook of Epilepsy Surgery, Bangkok, Chula Press (2009) (Thai)
Thesis
- 2008-2010: Osteoporosis in Thai Epileptic Patients with Long Term Antiepileptic Drugs Therapy
Clinical Trial Experience
- 2009-2010: Prevention of cerebrovascular and cardiovascular Events of ischemic origin with Terotroban in patients with a history of ischaemic stroke or Transient ischaemic attack, An international, randomized double-blind, two parallel group study comparing terutroban 30 mg o.d. versus aspirin 100 mg o.d. administered orally for a 3-year mean duration (event driven trial) (The PERFORM Study), Co-investigator
- 2009-2010: A randomised, double-blind, parallel-group placebo-controlled phase III study to evaluate the efficacy and safety of desmoteplase in subjects with acute ischemic stroke (DIAS-3), Co-investigator
- 2009-2010: Bionylated Idaparinux Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Arterial Fibrillation (BOREALIS-AF), Co-investigator
Extracurricular Activities
- Creator of:
- Proforma for Peripheral Nerve Examination for Specialty Clinic
- Status Epilepticus Effective Protocol for Adult Patients (>16 years old)
- RCP consult with members about Commentary Magazine group discussion (RCP, 1st Oct 2014)


ช้อปที่ LINE Shopping
ช้อปที่ Health Plaza